Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stone Disease

Inclusion Criteria: * Male or female aged ≥ 18 years to ≤ 75 years. * One urinary stone-apparent on a computed tomography (CT) scan within 14 days prior to study enrollment * Stone size, as estimated by pre-procedure CT, with all dimensions 15 mm or less. * Provides written informed consent * Understands and accepts the study requirements Exclusion Criteria: * Age less than 18 years of age or over 75 years of age * Diagnosis of radiolucent stones * Diagnosis of stones in the lower pole of kidney * History of cystinuria * Urine pH below 5.5 * Current untreated urinary tract infection * Pregnancy * Coagulation abnormality or taking prescription anticoagulants. Aspirin usage will be discontinued at least 7 days prior to enrollment at the discretion of the attending physician. * Mobility issues - unable to comfortably lie still for up to 30 minutes or unable to roll from back to side * Known hypersensitivity to conductivity gel * Vulnerable individuals (mentally disabled, physically disabled, prisoner, etc.) * Body mass index greater than 35 * American Society of Anesthesiologists (ASA) score of 3 or greater general anesthesia risk level * Known sensitivity to possible medications used before, during, or after the ELS procedure, including but not limited to the following: sedative agents, general anaesthetics, topical anaesthetics, and opioid analgesics. * Enrollment in another research study or previous participation within 30 days of enrollment.